TariffloLookup
Tarifflo homeLoginSign up free
Tarifflo/Companies/SUN PHARMACEUTICALSSnapshot · Q1 2026 (Jan – Mar)
Importer profile· US

SUN PHARMACEUTICALS

SUN PHARMACEUTICALS supplier risk profile Q1 2026: 107 shipments, 8 suppliers, India-dominant pharma imports.

Supplier score
74B
/ 100
Q1 shipments
107
Tier-1 suppliers
8
Source countries
4
Top country
India · 73%
Q1 2026 overview

What this importer's trade footprint looks like

SUN PHARMACEUTICALS imported 107 shipments in Q1 2026 across 8 suppliers and 4 countries. India dominates the sourcing footprint, accounting for 73% of all shipments, with SUN PHARMACEUTICAL (India) as the primary supplier at 68 shipments. The company sources exclusively within HS Chapter 30 (Pharmaceutical Products), reflecting a concentrated, vertically-integrated supply chain. Netherlands and Israel account for smaller volumes at 8% and 3% respectively.

Compliance

Sanctions watchlist & forced-labor exposure

Sanctions screen
3 flagged suppliers
  • SUN PHARMACEUTICAL
    Matches T AND N PHARMACEUTICAL CO, INC · 65% similarity
    SAM ExclusionsOFAC SDNUS Trade CSLTW SHTC
  • SUN PHARMACEUTICAL
    Matches T AND N PHARMACEUTICAL CO, INC · 65% similarity
    SAM ExclusionsOFAC SDNUS Trade CSLTW SHTC
  • TARO PHARMACEUTICAL
    Matches T AND N PHARMACEUTICAL CO, INC · 70% similarity
    SAM ExclusionsOFAC SDNUS Trade CSLTW SHTC
UFLPA forced-labor proximity
No suppliers in proximity to documented sites

Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.

Three names matching SUN PHARMACEUTICALS appear on sanctions watchlists during the review period. The importer shows no identified suppliers with documented Uyghur Forced Labor Prevention Act (UFLPA) exposure.

Risk score

Composite breakdown · 74 / 100

Activity
77
Diversification
42
Stability
80
Recency
100
Forwarder-clean
100
HS consistency
100
Forced-labor proximity
100
Sanctions clean
38
Tier 1

Top suppliers

8 distinct tier-1 suppliers in Q1 2026

SUN PHARMACEUTICALIndia68
SUN PHARMACEUTICALNetherlands9
SUN PHARMACEUTICAL LIMIIndia4
TARO PHARMACEUTICALIsrael3
GLAND PHARMAIndia3
SUN PHARMACEUTICAL LIMITIndia2
COHANCE LIFESCIENCESIndia1
ALKALOIDA CHEMICAL ZRTGermany1
Geography

Country mix

Share of Q1 2026 inbound shipments by source country

India
73%
78
Netherlands
8%
9
Israel
3%
3
Germany
1%
1
Cargo

Top HS codes

HS 300490
11 shipments
10% of mix
Locked

Tier 2 / Tier 3 supplier graph

1 tier-2 + 11 tier-3 nodes mapped - sign up to see them.

Tier-2 supplier #1 · CN
Tier-3 supplier #2 · CN
Tier-2 supplier #3 · CN
Tier-3 supplier #4 · CN
Tier-2 supplier #5 · CN
Tier-3 supplier #6 · CN
Tier-2 supplier #7 · CN
Tier-3 supplier #8 · CN
Unlock the full graph

See live data, not just the Q1 2026 (Jan – Mar) snapshot.

Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.

Create free account
Methodology. Snapshot built from US Customs AMS import and export bill-of-lading records arrived between Q1 2026 (Jan – Mar). Supplier risk score is a composite of activity, diversification, stability, recency, forwarder-cleanness, HS consistency, sanctions screen, and forced-labor proximity. Sanctions screen runs trigram similarity against the OpenSanctions FTM corpus (4.2M+ records, 32,982 sanctioned entities, 91,894 names + aliases). Forced-labor proximity is a haversine distance from each CN supplier's resolved coordinate to the nearest of 380 documented facilities in the ASPI Xinjiang Data Project. This page shows the Q1 2026 (Jan – Mar) snapshot only - sign up for live updates.
Tarifflo Logo

AI-driven trade automation platform
for modern companies.

Platform

Classifications
ABI Filing
API Access

Company

Contact

Resources

Help Center

Legal

Privacy
Terms

© 2026 Tarifflo, Inc. All rights reserved.